This podcast features Brian Chapman, David Jackson and Mark Saunders sharing their perspectives.
COVID-19 has accelerated many trends that were only starting to emerge in healthcare before 2020. It led to an inflection point, bringing in new opportunities and challenges in how pharma and medtech companies serve patients and other customers. In this podcast, we explore COVID-19 not just as a unique event, but in terms of the wider trends we anticipate playing out. We discuss how pharma and medtech companies need to prepare and invest to adapt to these trends in the future.